Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 7 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalent Inc | CTLT | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 56.03 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 56.03 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 7 | - | 31.45 - 60.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:10:13 | 7 | $ 55.59 | USD |
Catalent (CTLT) Options Flow Summary
Catalent Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.13B | 180.74M | - | 4.26B | -256M | -1.42 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Catalent News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTLT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 56.01 | 56.53 | 55.42 | 55.88 | 1,595,200 | 0.02 | 0.04% |
| 1 Month | 56.45 | 57.1999 | 55.42 | 56.38 | 1,595,124 | -0.42 | -0.74% |
| 3 Months | 52.46 | 60.20 | 51.54 | 57.22 | 2,804,924 | 3.57 | 6.81% |
| 6 Months | 42.46 | 60.20 | 31.8001 | 49.35 | 2,504,686 | 13.57 | 31.96% |
| 1 Year | 44.57 | 60.20 | 31.45 | 45.40 | 2,925,720 | 11.46 | 25.71% |
| 3 Years | 115.00 | 142.64 | 31.45 | 64.11 | 2,046,131 | -58.97 | -51.28% |
| 5 Years | 44.26 | 142.64 | 31.04 | 67.10 | 1,662,235 | 11.77 | 26.59% |
Catalent Description
| Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents. |
